(1-piperidino)-1-piperidino] carbonyloxycamptothecin or Irinotecan] is a carbamate prodrug that is activated in vivo by carboxylesterase (CES)-2 to SN-38 (7-ethyl-10-hydroxycamptothecin), a potent topoisomerase I inhibitor. There is high interindividual variation when CPT-11 is used in the treatment of colorectal cancer. Several splice variants of CES2 are reported in the expressed sequence tag database. Real-time polymerase chain reaction was used to determine the abundance of the CES2 and splice variant of human carboxylesterase 2 (CES2⌬ 458 -473 ) transcripts in 10 paired samples of human tumor and normal colon tissue. The results showed that the CES2⌬ 458 -473 transcript accounts for an average of 6% of total CES2 transcripts in colon tissue, and there is large interindividual variation in CES2 expression in both tumor and normal colon samples. The carboxylesterase activity of the colon samples was determined by 4-methylumbelliferyl acetate hydrolysis assays and nondenaturing polyacrylamide gel electrophoresis followed by activity staining. Significant, positive correlations were found between CES2 expression levels and both measures of carboxylesterase activity. We cloned and expressed the CES2⌬ 458 -473 protein in Sf9 insect cells. The purification profiles and preliminary characterization of the CES2⌬ 458 -473 protein indicated that the expressed protein is folded and glycosylated like CES2. However, in vitro assays show that the CES2⌬ 458 -473 protein lacks 4-methylumbelliferyl acetate and irinotecan hydrolase activities. In conclusion, we found that the CES2⌬ 458 -473 protein is an inactive splice variant of CES2 and that its transcript is spliced at a relatively constant rate in tumor and normal colon tissue.CPT-11 is a semisynthetic camptothecin derivative that is approved for the treatment of metastatic colorectal cancer. Currently, several studies are evaluating the efficacy of CPT-11 in the treatment of solid tumors (Conroy et al., 2005;Delord et al., 2005;Reardon et al., 2005;Stathopoulos et al., 2005). Metabolism of CPT-11 is complex with the involvement of several enzymatic reactions (Rivory, 2000;Slatter et al., 2000). CYP3A4-dependent oxidation of CPT-11 results in the formation of APC and NPC (Haaz et al., 1998;Sai et al., 2001); carboxylesterase-dependent hydrolysis of CPT-11 and NPC results in the formation of the active metabolite SN-38 (Humerickhouse et al., 2000;Khanna et al., 2000;Sanghani et al., 2004) and UGT1A1 glucuronidates SN-38 to form the inactive SN-38-glucuronide (Hanioka et al., 2001). The key step in the metabolism of CPT-11 is its activation by carboxylesterases. There are three known human carboxylesterases, CES1, CES2, and CES3. CES2 has 100-and 2000-fold greater catalytic efficiency for irinotecan hydrolysis than CES1 and CES3, respectively . Therefore, CES2, which is predominantly expressed in the liver, small intestines, and colon (Satoh et al., 2002), is the most important carboxylesterase for the activation of CPT-11. Clinical data, reported by Xu et al....
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.